Suppr超能文献

BRCA2基因变异携带者、生殖因素与乳腺癌风险

BRCA2 mutation carriers, reproductive factors and breast cancer risk.

作者信息

Tryggvadottir Laufey, Olafsdottir Elinborg J, Gudlaugsdottir Sigfridur, Thorlacius Steinunn, Jonasson Jon G, Tulinius Hrafn, Eyfjord Jorunn E

机构信息

Icelandic Cancer Registry, Reykjavík, Iceland.

出版信息

Breast Cancer Res. 2003;5(5):R121-8. doi: 10.1186/bcr619. Epub 2003 Jun 24.

Abstract

BACKGROUND

Germline mutations in the BRCA genes dramatically increase the risk of breast cancer. In the general population, breast cancer risk is affected by age at menarche, by age at first birth, by the number of births and by the duration of breast feeding. Whether this is true for mutation carriers is not clear.

METHODS

In a case-control study, nested in a population-based cohort of the Icelandic Cancer Detection Clinic, two groups of cases were defined, matched on year of birth, on age at diagnosis and on age when giving information on reproductive factors: 100 carriers of the Icelandic founder BRCA2 mutation 999del5, and 361 BRCA2-negative cases. The mean age at diagnosis was 48 years. There were 1000 women in a matched group of unaffected controls. Conditional logistic regression was used for the analysis.

RESULTS

An increased number of births was associated with a decreased risk of breast cancer in BRCA2-negative cases but not in BRCA2-positive cases. A negative association between risk and duration of breast feeding was observed only in the mutation carriers. These associations were not statistically significant, but the effects of the two variables differed significantly according to mutation status (P = 0.007 and P = 0.045 for interaction with number of births and with duration of breast feeding, respectively). This was maintained when limiting the analysis to women diagnosed older than the age of 40 years.

CONCLUSION

The association between breast cancer and the number of pregnancies and between breast cancer and the duration of breast feeding was not the same for carriers and noncarriers of a detrimental BRCA2 mutation. In the context of other epidemiological and laboratory studies, this may indicate that the product of the BRCA2 gene has a function relating to the differentiation of epithelial tissue in the breast.

摘要

背景

BRCA基因的种系突变会显著增加患乳腺癌的风险。在一般人群中,乳腺癌风险受初潮年龄、首次生育年龄、生育次数和母乳喂养时长的影响。对于突变携带者而言是否如此尚不清楚。

方法

在一项病例对照研究中,该研究嵌套于冰岛癌症检测诊所的一项基于人群的队列研究中,定义了两组病例,根据出生年份、诊断年龄以及提供生殖因素信息时的年龄进行匹配:100名冰岛始祖BRCA2突变999del5的携带者,以及361名BRCA2阴性病例。诊断时的平均年龄为48岁。在一组匹配的未受影响的对照中有1000名女性。采用条件逻辑回归进行分析。

结果

生育次数增加与BRCA2阴性病例患乳腺癌风险降低相关,但与BRCA2阳性病例无关。仅在突变携带者中观察到风险与母乳喂养时长之间存在负相关。这些关联无统计学意义,但这两个变量的效应根据突变状态有显著差异(分别与生育次数和母乳喂养时长的交互作用的P值为0.007和0.045)。当将分析限制在40岁以上诊断的女性时,这种情况依然存在。

结论

对于有害BRCA2突变的携带者和非携带者而言,乳腺癌与怀孕次数以及乳腺癌与母乳喂养时长之间的关联并不相同。结合其他流行病学和实验室研究来看,这可能表明BRCA2基因的产物具有与乳腺上皮组织分化相关的功能。

相似文献

1
BRCA2 mutation carriers, reproductive factors and breast cancer risk.
Breast Cancer Res. 2003;5(5):R121-8. doi: 10.1186/bcr619. Epub 2003 Jun 24.
2
Population-based study of changing breast cancer risk in Icelandic BRCA2 mutation carriers, 1920-2000.
J Natl Cancer Inst. 2006 Jan 18;98(2):116-22. doi: 10.1093/jnci/djj012.
4
Breast-feeding and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
J Natl Cancer Inst. 2004 Jul 21;96(14):1094-8. doi: 10.1093/jnci/djh211.
5
Parity and the risk of breast and ovarian cancer in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2010 Jan;119(1):221-32. doi: 10.1007/s10549-009-0394-1. Epub 2009 Apr 16.
6
Prostate cancer progression and survival in BRCA2 mutation carriers.
J Natl Cancer Inst. 2007 Jun 20;99(12):929-35. doi: 10.1093/jnci/djm005. Epub 2007 Jun 12.
7
Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res. 2006;8(6):R72. doi: 10.1186/bcr1630.
8
Age at first birth and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
Breast Cancer Res Treat. 2007 Oct;105(2):221-8. doi: 10.1007/s10549-006-9441-3. Epub 2007 Jan 24.
9
Risk factors for carcinoma of the fallopian tube in women with and without a germline BRCA mutation.
Gynecol Oncol. 2010 Aug 1;118(2):155-9. doi: 10.1016/j.ygyno.2010.03.009. Epub 2010 May 10.
10
Skewed X chromosome inactivation and breast and ovarian cancer status: evidence for X-linked modifiers of BRCA1.
J Natl Cancer Inst. 2008 Nov 5;100(21):1519-29. doi: 10.1093/jnci/djn345. Epub 2008 Oct 28.

引用本文的文献

1
Pregnancy after breast cancer: latest evidence and practical considerations.
Ther Adv Med Oncol. 2025 Jun 18;17:17588359251346648. doi: 10.1177/17588359251346648. eCollection 2025.
2
Cancer Is Associated with the Emergence of Placenta-Reactive Autoantibodies.
Biomedicines. 2023 Jan 23;11(2):316. doi: 10.3390/biomedicines11020316.
3
A bibliometric analysis of the top 100 most cited papers and research trends in breast cancer related BRCA1 and BRCA2 genes.
Medicine (Baltimore). 2022 Sep 23;101(38):e30576. doi: 10.1097/MD.0000000000030576.
4
A human breast atlas integrating single-cell proteomics and transcriptomics.
Dev Cell. 2022 Jun 6;57(11):1400-1420.e7. doi: 10.1016/j.devcel.2022.05.003. Epub 2022 May 25.
5
Reproductive factors as risk modifiers of breast cancer in mutation carriers and high-risk non-carriers.
Oncotarget. 2017 Oct 31;8(60):102110-102118. doi: 10.18632/oncotarget.22193. eCollection 2017 Nov 24.
6
Oestrogen receptor status, treatment and breast cancer prognosis in Icelandic BRCA2 mutation carriers.
Br J Cancer. 2016 Sep 27;115(7):776-83. doi: 10.1038/bjc.2016.249. Epub 2016 Aug 18.
7
Iceland-genetic counseling services.
J Genet Couns. 2013 Dec;22(6):907-10. doi: 10.1007/s10897-013-9640-0. Epub 2013 Aug 15.
8
BRCA1 and BRCA2 mutations and female fertility.
Curr Opin Obstet Gynecol. 2013 Jun;25(3):207-13. doi: 10.1097/GCO.0b013e32835f1731.
9
Pregnancy after Breast Cancer: Myths and Facts.
Breast Care (Basel). 2012 Jun;7(3):210-214. doi: 10.1159/000339885. Epub 2012 Jun 27.

本文引用的文献

1
Modifiers of risk of hereditary breast and ovarian cancer.
Nat Rev Cancer. 2002 Feb;2(2):113-23. doi: 10.1038/nrc726.
2
Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.
J Natl Cancer Inst. 2002 Dec 4;94(23):1773-9. doi: 10.1093/jnci/94.23.1773.
3
BRCA1 and BRCA2 bind Stat5a and suppress its transcriptional activity.
FEBS Lett. 2002 Dec 4;532(1-2):247-52. doi: 10.1016/s0014-5793(02)03684-0.
4
Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer.
Genet Epidemiol. 2002 Nov;23(4):349-63. doi: 10.1002/gepi.10188.
5
The effect of a single BRCA2 mutation on cancer in Iceland.
J Med Genet. 2002 Jul;39(7):457-62. doi: 10.1136/jmg.39.7.457.
6
Oral contraceptives and risk of familial breast cancer.
Cancer Detect Prev. 2002;26(1):23-7. doi: 10.1016/s0361-090x(02)00004-1.
7
Breast cancer risk in Ashkenazi BRCA1/2 mutation carriers: effects of reproductive history.
Epidemiology. 2002 May;13(3):255-61. doi: 10.1097/00001648-200205000-00004.
8
Breast cancer risk factors and age at diagnosis: an Icelandic cohort study.
Int J Cancer. 2002 Apr 1;98(4):604-8. doi: 10.1002/ijc.10217.
9
Mammary gland architecture as a determining factor in the susceptibility of the human breast to cancer.
Breast J. 2001 Sep-Oct;7(5):278-91. doi: 10.1046/j.1524-4741.2001.21033.x.
10
Cancer susceptibility and the functions of BRCA1 and BRCA2.
Cell. 2002 Jan 25;108(2):171-82. doi: 10.1016/s0092-8674(02)00615-3.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验